Recent News
BioRx Expands Therapy Offering to Patients with Hereditary Angioedema
“Specialty Pharmaceutical Risk Mitigation” by Eric Hill, BioRx Vice President, Self Funding Magazine Newsletter
BioRx provides Glassia(TM) and Aralast NP to patients with alpha-1 antitrypsin deficiency
BioRx Offers Scholarships to Bleeding Disorders Community
BioRx President Phil Rielly Wins Ernst & Young Entrepreneur of the Year Award
10828 Kenwood Rd Cincinnati, OH 45242 Phone: 866-442-4679 Fax: 877-588-8470
